Isik, B., Davey, M. G., Jaffer, A. A., Buckley, J., Brown, J. A. L., Baban, C., . . . Tormey, S. (2025). Assessing the clinical utility of pre-operative neutrophil–lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer. Breast Cancer Research and Treatment, 210(3), 783-790. https://doi.org/10.1007/s10549-025-07615-8
Chicago-referens (17:e uppl.)Isik, Burce, Matthew G. Davey, Alisha A. Jaffer, Juliette Buckley, James A. L. Brown, Chwanrow Baban, Bridget Anne Merrigan, och Shona Tormey. "Assessing the Clinical Utility of Pre-operative Neutrophil–lymphocyte Ratio as a Predictor of Clinicopathological Parameters in Patients Being Treated for Primary Breast Cancer." Breast Cancer Research and Treatment 210, no. 3 (2025): 783-790. https://doi.org/10.1007/s10549-025-07615-8.
MLA-referens (9:e uppl.)Isik, Burce, et al. "Assessing the Clinical Utility of Pre-operative Neutrophil–lymphocyte Ratio as a Predictor of Clinicopathological Parameters in Patients Being Treated for Primary Breast Cancer." Breast Cancer Research and Treatment, vol. 210, no. 3, 2025, pp. 783-790, https://doi.org/10.1007/s10549-025-07615-8.
